by Eric Christianson | Nov 14, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
When I was in school, acetaminophen was considered the go agent for the management of osteoarthritis pain. While acetaminophen in osteoarthritis is still possibly a 2nd or 3rd line consideration, more evidence has come to light over the years that maybe it really...
by Eric Christianson | Oct 3, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Patients will frequently ask me what supplements they should use to help treat their conditions and more often, they begin to take something even prior to asking. I was recently asked my thoughts on glucosamine and chondroitin for arthritis, and more specifically,...
by Eric Christianson | Mar 18, 2020 | Clinical Pharmacy News and New Drug Updates
I’m seeing this article all over the place recommending to avoid NSAIDs in patients who have an infection with the new COVID-19 coronavirus. My question is, where’s the evidence? The only thing I can find is that it was based upon is a scientific theory as...
by Eric Christianson | Oct 2, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
A 68-year-old male presents to your care with chronic back pain. He is taking ketorolac and states that NSAIDs are the mainstay of pain relief. He won’t take opioids due to a family history of addiction. Acetaminophen and other medications he has tried in the...
by Eric Christianson | Sep 18, 2019 | Drug Interaction Case Studies and Education For Pharmacists
Lithium has numerous clinical pearls that are essential to remember. Of all the educational points about this medication, you must remember some of these important lithium drug interactions. The list below is not an all-inclusive list, just ones that more commonly...
